Choose Your language:
- Testimonials
-
i have recept my viagra thanks you
- robert
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- BG Medicine Announces Publication of First Study on Use of Galectin-3 in ... - MarketWatch (press release)
- BG Medicine Announces Publication of First Study on Use of Galectin-3 in
- LUNAR Examines Cholesterol-Lowering Effects of CRESTOR(R) (rosuvastatin ... - MarketWatch (press release)
- LUNAR Examines Cholesterol-Lowering Effects of CRESTOR(R) (rosuvastatin
- Statins Before Stenting Cut Risks - MedPage Today
- Statins Before Stenting Cut RisksMedPage TodayIn a randomized trial of chronic statin users, giving a loading dose of either rosuvastatin or atorvastatin within 24 hours of stenting substantially reduced levels of the cardiac cell death marker CK-MB compared with no 're-load' (both P=0
- BG Medicine Announces Publication of First Study on Use of Galectin-3 in ... - GlobeNewsWire (press release)
- BG Medicine Announces Publication of First Study on Use of Galectin-3 in
- Antibacterial activity of statins: a comparative study of Atorvastatin ... - 7thSpace Interactive (press release)
- Antibacterial activity of statins: a comparative study of Atorvastatin
